<table width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col align="left" span="1" valign="top" width="24%"></col>
<col align="center" span="1" valign="top" width="20%"></col>
<col align="center" span="1" valign="top" width="20%"></col>
<col align="left" span="1" valign="top" width="36%"></col>
<tbody>
<tr>
<th colspan="4">Digoxin concentrations increased greater than 50%</th>
</tr>
<tr>
<th colspan="1"></th>
<th colspan="1">Digoxin Serum Concentration Increase</th>
<th colspan="1">Digoxin AUC Increase</th>
<th colspan="1">Recommendations</th>
</tr>
<tr>
<td>Amiodarone</td>
<td>70%</td>
<td>NA</td>
<td>Measure serum digoxin concentrations before initiating concomitant drugs. Reduce digoxin concentrations by decreasing dose by approximately 30 to 50% or by modifying the dosing frequency and continue monitoring.</td>
</tr>
<tr>
<td>Captopril</td>
<td>58%</td>
<td>39%</td>
</tr>
<tr>
<td>Clarithromycin</td>
<td>NA</td>
<td>70%</td>
</tr>
<tr>
<td>Dronedarone</td>
<td>NA</td>
<td>150%</td>
</tr>
<tr>
<td>Gentamicin</td>
<td>129 to 212%</td>
<td>NA</td>
</tr>
<tr>
<td>Erythromycin</td>
<td>100%</td>
<td>NA</td>
</tr>
<tr>
<td>Itraconazole</td>
<td>80%</td>
<td>NA</td>
</tr>
<tr>
<td>Nitrendipine</td>
<td>57%</td>
<td>15%</td>
</tr>
<tr>
<td>Propafenone</td>
<td>NA</td>
<td>60 to 270%</td>
</tr>
<tr>
<td>Quinidine</td>
<td>100%</td>
<td>NA</td>
</tr>
<tr>
<td>Ranolazine</td>
<td>50%</td>
<td>NA</td>
</tr>
<tr>
<td>Ritonavir</td>
<td>NA</td>
<td>86%</td>
</tr>
<tr>
<td>Tetracycline</td>
<td>100%</td>
<td>NA</td>
</tr>
<tr>
<td>Verapamil</td>
<td>50 to 75%</td>
<td>NA</td>
</tr>
<tr>
<td>
<content stylecode="bold">Digoxin concentrations increased less than 50%</content>
</td>
</tr>
<tr>
<td>Atorvastatin</td>
<td>22%</td>
<td>15%</td>
<td>Measure serum digoxin concentrations before initiating concomitant drugs. Reduce digoxin concentrations by decreasing the dose by approximately 15 to 30% or by modifying the dosing frequency and continue monitoring.</td>
</tr>
<tr>
<td>Carvedilol</td>
<td>16%</td>
<td>14%</td>
</tr>
<tr>
<td>Diltiazem</td>
<td>20%</td>
<td>NA</td>
</tr>
<tr>
<td>Indomethacin</td>
<td>40%</td>
<td>NA</td>
</tr>
<tr>
<td>Nefazodone</td>
<td>27%</td>
<td>15%</td>
</tr>
<tr>
<td>Nifedipine</td>
<td>45%</td>
<td>NA</td>
</tr>
<tr>
<td>Propantheline</td>
<td>24%</td>
<td>24%</td>
</tr>
<tr>
<td>Quinine</td>
<td>NA</td>
<td>33%</td>
</tr>
<tr>
<td>Saquinavir</td>
<td>27%</td>
<td>49%</td>
</tr>
<tr>
<td>Spironolactone</td>
<td>25%</td>
<td>NA</td>
</tr>
<tr>
<td>Telmisartan</td>
<td>20 to 49%</td>
<td>NA</td>
</tr>
<tr>
<td>Tolvaptan</td>
<td>30%</td>
<td>NA</td>
</tr>
<tr>
<td>Trimethoprim</td>
<td>22 to 28%</td>
<td>NA</td>
</tr>
<tr>
<td>
<content stylecode="bold">Digoxin concentrations increased, but magnitude is unclear</content>
</td>
</tr>
<tr>
<td>Alprazolam, azithromycin, cyclosporine, diclofenac, diphenoxylate, epoprostenol, esomeprazole, ibuprofen, ketoconazole, lansoprazole, metformin, omeprazole, quinine, rabeprazole</td>
<td>Measure serum digoxin concentrations before initiating concomitant drugs. Continue monitoring and reduce digoxin dose as necessary.</td>
</tr>
<tr>
<td>
<content stylecode="bold">Digoxin concentrations decreased</content>
</td>
</tr>
<tr>
<td>Acarbose, activated charcoal, albuterol, antacids, certain cancer chemotherapy or radiation therapy, cholestyramine, colestipol, extenatide, kaolin-pectin, meals high in bran, metoclopramide, miglitol, neomycin, penicillamine, phenytoin, rifampin, St. John's Wort, sucralfate, sulfasalazine</td>
<td>Measure serum digoxin concentrations before initiating concomitant drugs. Continue monitoring and increase digoxin dose by approximately 20 to 40% as necessary.</td>
</tr>
<tr>
<td>
<content stylecode="bold">No significant Digoxin exposure changes</content>
</td>
</tr>
<tr>
<td>Please refer to section 12 for a complete list of drugs which were studied but reported no significant changes on digoxin exposure.</td>
<td>No additional actions are required.</td>
</tr>
</tbody>
</table>